Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immungenetics AG
Rostock, Mecklenburg-Vorpommern, Germanyimmungenetics.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Immungenetics AG has developed a novel approach combining early diagnosis and treatment to address causative mechanisms in Alzheimer's Disease. Their lead candidate aims to improve amyloid beta monomer clearance and restore autophagic flux, targeting both Aβ and Tau pathology. The company sponsors an open-label, multicenter Phase II trial ("drainAD") evaluating the amyloid beta draining effect of Thiethylperazine in early-to-mild dementia due to Alzheimer's Disease. Additional programs target neurodegeneration, mitochondrial dysfunctions, autoimmunity, metabolic syndromes, inflammation, and lifespan extension.
- Therapeutic areas
- OtherImmunologyNeurologyMetabolic Disorders
- Modalities
- Biological productsSmall molecules (e.g., Thiethylperazine/TEP)Modulation of ABC-transporter proteins at the blood-brain barrier
- Industry
- Biotech
Beyond the preview
Go deeper on Immungenetics AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immungenetics AG.